CD4 and chronic obstructive pulmonary disease: An imbalance between proinflammatory and anti-inflammatory immune responses mediated by different subsets of CD4+ T lymphocytes, such as Th17 and regulatory Treg cells, has also been described in COPD patients, but their precise role is unclear (13, 14).